Antibodies to anionic phospholipids and anti-β2-GPI: Association with thrombosis and thrombocytopenia in systemic lupus erythematosus

Human Immunology

Volumn 64, Issue 2, 2003, Pages 265-273

  Amoroso, Antonio ^a   Mitterhofer, Anna P ^a   Del Porto, Flavia ^a   Garzia, Pierluigi ^a   Ferri, Gianni M ^a   Galluzzo, Sara ^a   Vadacca, Marta ^b   Caccavo, Domenico ^c   Afeltra, Antonella ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c UNIVERSITY OF BARI   (Italy)

Author keywords

Anti 2 GPI; Antinegatively charged phospholipid antibodies; SLE; Thrombocytopenia; Thrombosis

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PHOSPHATIDIC ACID ANTIBODY; PHOSPHATIDYLINOSITOL ANTIBODY; PHOSPHATIDYLSERINE ANTIBODY; PHOSPHOLIPID ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0037316336     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(02)00789-9     Document Type: Article

References (29)

1. Hughes GRV: Thrombosis, abortion, cerebral disease and lupus anticoagulant. Br Med J 187:1088, 1983.
2. Hughes GRV: The anticardiolipin syndrome. Clin Exp Rheumatol 3:285, 1985.
3. Harris EN, Baguley E, Asherson RA, Hughes GRV: Clinical and serological features of the antiphospholipid syndrome. Br J Rheumatol 26:19, 1987.
4. Mackworth-Young CG, David J, Loizou S, Walport MJ: Primary antiphospholipid syndrome: features in patients with raised anticardiolipin antibodies and in other disorders. Br J Rheumatol 26:94, 1987.
5. Asherson RA, Khamashta MA, Ordi-Ros J, Derksen RH, Machin SJ, Barquinero J, Outt HH, Harris EN, Vilardell-Torres M, Hughes GR: The "primary" antiphospholipid antibody syndrome: major clinical and serological features. Medicine 68:366, 1989.
6. Alarcón-Segovia D, Sanchez-Guerrero J: Primary antiphospholipid syndrome. J Rheumatol 16:482, 1989.
7. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Domenech I, Aydintug AO, Jedryka-Goral A, de Roman E: Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1000 patients. Medicine (Baltimore) 72:113, 1993.
8. Alarcón-Segovia D: Antiphospholipid syndrome within systemic lupus erythematosus. Lupus 3:289, 1994.
9. Asherson RA, Cervera R: "Primary," "secondary," and other variants of the antiphospholipid syndrome. Lupus 3:293, 1994.
10. Carreras LO, Forastiero RR, Martinuzzo ME: Which are the best biological markers of the antiphospholipid syndrome? J Autoimmun 15:163, 2000.
11. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA: Anti-phospholipid: antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 87:4120, 1990.
12. Galli M, Comfurius P, Maassen C, Hemker HC, de Baets MH, van Breda-Vriesman PJ, Barbui T, Zwaal RF, Bevers EM: Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma cofactor. Lancet 355:1544, 1990.
13. Rauch J, Janoff AS: The nature of anti-phospholipid antibodies. J Rheumatol 19:1782, 1992.
14. 2-glycoprorein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 93:181, 1992.
15. Gharavi AE, Harris EN, Sammaritano LR: Do patients with antiphospholipid syndrome have autoantibodies to beta (2) glycoprotein I? J Lab Clin Med 122:426, 1993.
16. 2-glycoprotein I in patients with primary antiphospholipid syndrome. J Rheumatol 22:1894, 1995.
17. 2-GP I are two distinct populations of autoantibodies. Thromb Haemost 75:303, 1996.
18. 2-glycoprotein I - a specific marker for the antiphospholipid syndrome. Clin Exp Immunol 109:304, 1997.
19. Harris EN, Pierangeli SS: "Equivocal" antiphospholipid syndrome. J Autoimmun 15:81, 2000.
20. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271, 1982.
21. Hochberg MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725, 1997.
22. Harris EN: The Second International Anticardiolipin Standardisation Worshop/The Kingston Antiphospholipid Antibody Study (KAPS) group. Am J Clin Pathol 94:476, 1990.
23. Lopez-Soto A, Cervera R, Font J, Bove A, Reverter JC, Munoz FJ, Miret C, Espinosa G, Ordinas A, Ingelmo M: Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients. Clin Exp Rheumatol 15:143, 1997.
24. Bertolaccini ML, Roch B, Amengual O, Atsumi T, Khamashta MA, Hughes GRV: Multiple antiphospholipid tests do not increase the diagnostic yield in antiphospholipid syndrome. Br J Rheumatol 37:1229, 1998.
25. Harris EN: Antiphospholipid antibodies. Br J Haematol 74:1, 1990.
26. Sheng Y, Kandiah DA, Krilis SA: Anti-beta 2-glycoprotein I autoantibodies from patients with the "antiphospholipid" syndrome bind to beta 2-glycoprotein I with low affinity: dimerization of beta 2-glycoprotein I induces a significant increase in anti-beta 2-glycoprotein I antibody affinity. J Immunol 164:2038, 1998.
27. Roubey RA, Eisenberg RA, Harper MF, Winfield JB: Anticardiolipin autoantibodies recognize beta 2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding. J Immunol 154:954, 1995.
28. Tincani A, Spatola L, Prati E, Allegri F, Ferremi P, Cattaneo R, Meroni P, Balestrieri G: The anti-beta-2glycoprotein I activity in human anti-phospholipid sindrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes located on native beta2-glycoprotein I and preserved during species' evolution. J Immunol 157:5732, 1996.
29. Toschi V, Motta A, Castelli C, Gibelli S, Cimminiello C, Molaro GL, Gibelli A: Prevalence and clinical significance of antiphospholipid antibodies to noncardiolipin antigens in systemic lupus erythematosus. Haemostasis 23:275, 1993.